BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lahbabi M, Aqodad N, Ibrahimi A, Lahlou M, Aqodad H. Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy. World J Hepatol 2012; 4(6): 196-198 [PMID: 22761971 DOI: 10.4254/wjh.v4.i6.196]
URL: https://www.wjgnet.com/1948-5182/full/v4/i6/196.htm
Number Citing Articles
1
Pietro Gareri, Rosa P. Cerra, Laura Greco, Tania Falbo, Carlo Torchia, Giuseppe Coppolino, Alberto Castagna, Giovanni Ruotolo. Parenteral amiodarone-induced hepatoxicity: when being earnest is an added valueGazzetta Medica Italiana Archivio per le Scienze Mediche 2019; 178(7-8) doi: 10.23736/S0393-3660.18.03868-8
2
Chia-Chi Chen, Chien-Chih Wu. Acute Hepatotoxicity of Intravenous AmiodaroneAmerican Journal of Therapeutics 2016; 23(1): e260 doi: 10.1097/MJT.0000000000000149
3
Jana Ďuricová, Marcela Káňová, Ivana Kacířová. Amiodarone induced acute hepatotoxicity during intravenous applicationKlinická farmakologie a farmacie 2018; 32(3): 34 doi: 10.36290/far.2018.031
4
Ji Hye Lee, Myug-Shin Kang, Tae-Hoon Kim, Dong Hee Shin, Rak Kyeong Choi, Su Jin Jung. A Case of Acute Hepatitis Associated with Intravenous Infusion Amiodarone in Patient with Atrial FibrillationSoonchunhyang Medical Science 2015; 21(2): 208 doi: 10.15746/sms.15.049
5
Joseph Offenbacher, Farnam Kazi, Niel Chen, Mohamed Mohamed, Jasmine Chacko, Nils Guttenplan, Vincent Nguyen. Immediate oral amiodarone re-challenge following the development of parenteral-induced acute liver toxicityWorld Journal of Emergency Medicine 2021; 12(4): 321 doi: 10.5847/wjem.j.1920-8642.2021.04.012
6
Wai Pok Vernon Chan, Michelle A. Hieger. Low-Dose Intravenous Amiodarone-Induced Acute Hepatic FailureAmerican Journal of Therapeutics 2022; 29(3): e364 doi: 10.1097/MJT.0000000000001398
7
Ninad Ramesh Varkhede, Shalu Jhajra, Deepak Suresh Ahire, Saranjit Singh. Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using liquid chromatography with high‐resolution mass spectrometry and multiple‐stage mass spectrometry: Characterization of the diquinone metabolite supposedly responsible for the drug's hepatotoxicityRapid Communications in Mass Spectrometry 2014; 28(4): 311 doi: 10.1002/rcm.6787
8
O.A. Diab, John Kamel, Ahmed Adel Abd-Elhamid. Predictors of intravenous amiodarone induced liver injuryThe Egyptian Heart Journal 2017; 69(1): 45 doi: 10.1016/j.ehj.2016.05.001
9
Ana Lopes dos Santos, Margarida Lagarto, Cláudio Gouveia. A Rare Case of Intravenous Amiodarone ToxicityCureus 2022;  doi: 10.7759/cureus.27958